Sodium Channel Blocker Toxicity


Article Author:
Kaylinn Dokken


Article Editor:
Patrick Fairley


Editors In Chief:
Donald Kushner
Annabelle Dookie


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Kyle Blair
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Daniyal Ameen
Altif Muneeb
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes
Komal Shaheen
Sandeep Sekhon


Updated:
11/20/2018 8:14:24 AM

Introduction

     Medications that act by sodium channel blockade have a wide variety of clinical applications. Broadly they include Vaughn Williams Class 1 antiarrhythmics, local anesthetics, many medications used to treat neuropathic pain (including tricyclic antidepressants (TCA)), anticonvulsants, and cocaine. Specific examples include quinidine and procainamide, (class 1A antiarrhythmics), lidocaine, mexiletine, and phenytoin (class 1B), flecainide and propafenone (class 1C), carbamazepine and lamotrigine. There are many TCAs, but only imipramine and amitriptyline continue to be used in the US today.[1] Insecticides also cause sodium channel blockade. Toxicity of all these substances, whether intentional or accidental, can lead to catastrophic effects including death.   It is essential to understand how these medications work, in order to effectively treat their toxicity and side effects.

Etiology

Sodium channel blocker toxicity results primarily from intentional overdose. However, patients or family members may report an inadvertent increase in medication doses or the addition of a new medication which might alter the typical elimination kinetics of the substance and lead to an unsuspected toxic dose.

Epidemiology

Most intentional poisonings involve the ingestion of multiple drugs. The exact numbers of people involved with sodium channel blocker toxicity are not readily available, but these agents are likely responsible for more fatal outcomes than many other medication classes.

Pathophysiology

There tends to be no significant effect on the AV node as it does not depend on fast sodium channels. Instead, sodium channel blockade produces a variety of cardiac effects as demonstrated by their impact on the myocyte action potential. With varying degrees of potency, class I agents decrease the slope and amplitude of phase 0, and thereby reduce the rate of depolarization and the conduction velocity through the myocyte. This leads to a slower depolarization of the cell and is important for the desired therapeutic suppression of tachydysrhythmias through reentrant mechanisms. Concomitant anticholinergic effects of many of these drugs can complicate their sodium channel effects.[2]

Toxicokinetics

Broadly speaking, sodium channel blockers cause metabolic, cardiac, and neurologic symptoms. This leads to hemodynamic compromise and metabolic acidosis, potentiating the effects of the medications and causing further sodium blockade.[1]  Propafenone in particular also has beta-blocking and calcium blocking activities which can worsen toxicity, leading to heart failure by decreased inotropy.[2]

Sodium channel blockers cross the blood-brain barrier and act through multiple mechanisms.  They inhibit the gamma-aminobutyric acid (GABA) system (primarily lidocaine), activate the sodium ouabain-sensitive current, stimulate 5-TH2C receptors, antagonize H1 receptors and block all noradrenaline activating effect. It is through these actions that adrenergic stimulation occurs. These medications in large doses are also pro-convulsant through the above mechanisms.[2]

Co-ingestion of other drugs can alter the elimination kinetics.  A recent case report describes how propafenone delayed the metabolism of metoprolol by inhibition of CYP2D. This interaction of the two medications led to a more profound toxicity, and in this case cardiovascular collapse.[3]

TCAs are well known for their concomitant anticholinergic effects but they also produce potassium channel blockade, peripheral alpha blockade, and norepinephrine reuptake blockade, all of which will potentially cloud the clinical presentation.

Evaluation

There is no classical findings or toxidrome in the setting of sodium channel blocker toxicity. Physical exam findings vary by the substance ingested.  Patients who have ingested tricyclic antidepressants often present with tachycardia, whereas those with ingestion of 'pure' sodium channel blocking medications can present with significant bradycardia.[4]

Patients with potential sodium channel blocker toxicity require an immediate electrocardiogram (ECG). Toxicity of sodium channel blockers leads to a widening of the QRS complex, lengthening of the QT interval, a new right axis deviation, bradydysrhythmias, ventricular tachycardia, ventricular fibrillation or torsades des pointes.[4] Brugada phenocopy, a sodium channelopathy disorder, can also be seen during acute toxicity.[5]

It is vital to consider and evaluate for any other co-ingestion. 

Obtain electrolyte, renal and hepatic profiles, acetaminophen level, salicylate level, arterial or venous blood gas, drug screen, and a complete blood count.  Evaluate for an anion gap, and osmolal gap as this could indicate coingestants not detectable on standard testing.

Treatment / Management

As is commonly the case, most over ingestions involve multiple agents; hence, one must maintain a high index of suspicion.

Immediate initial management must begin with an assessment of airway, breathing, and circulation.  Many patients present with hypotension, bradycardia or tachycardia and altered mental status.  An endotracheal tube or other advanced airways should be placed in patients who are unable to protect their airway.

The cornerstone of treatment is the administration of sodium bicarbonate. It is indicated for patients with an ECG demonstrating a QRS duration >100 ms or any suspicious QT prolongation or dysrhythmia.[4] Sodium bicarbonate is beneficial in raising the serum pH and increasing the extracellular sodium. Alkalinization leads to an increase of the electrochemical gradient across cell membranes which helps to offload sodium channels. It might also increase the protein binding of the offending agent. Patients should be given 1-2mEq/kg as a bolus dose.[1] Bolus doses can be administered until the QRS duration is less than 100 ms. This can be followed with a continuous infusion of sodium bicarbonate of 2-3 50mEq ampules in one liter of D5W.[4] Hypertonic saline has been used but is not routinely recommended; it remains an option in dire circumstances as reported in a case of flecainide overdose.[6]

Management of hypotension requires a combination of volume resuscitation and vasopressor and inotropic support. Use of inotropic agents such as dobutamine helps increase cardiac output while the effects of the toxicity dissipate. Addition of vasopressors such as norepinephrine, vasopressin, or epinephrine might be considered for hemodynamic support.  These agents lead to vasoconstriction and an increase in the systemic vascular resistance, resulting in increased systemic blood pressure.

Patients with sodium channel blocker toxicity from lidocaine have benefitted from the administration of 20% lipid emulsion if they are hemodynamically unstable.[7] The mechanism of action of lipid emulsion is unclear; however, it is hypothesized that it acts as a lipid sink, with an electrochemical gradient drawing the lidocaine into the lipid. Patients should be given a 1.5mL/kg bolus followed by a 0.25mL/kg infusion.[8] Few studies exist on lipid emulsion for other sodium channel toxicities. There is controversy over its utility in TCA overdose.

Extracorporeal membrane oxygenation (ECMO) has been used in a refractory case with reported survival.[6] In general, the drugs which cause sodium channel blockade toxicity are highly lipophilic, have a wide volume of distribution, and are not dialyzable.

Seizure management is accomplished with benzodiazepine medications, such as lorazepam and midazolam.  For refractory seizures, loading of antiepileptic medications such as levetiracetam is recommended.  Phenytoin and its derivatives should be avoided in this situation as phenytoin is itself a sodium channel blocker and will likely lead to clinical deterioration. Intubation and sedation with propofol should be considered for seizures refractory to other management.

Prognosis

Complications of sodium channel blocker toxicity include cardiogenic shock, hypotension, bradycardia or tachycardia, cardiovascular collapse, respiratory depression, encephalopathy, status epilepticus, and death.

The high mortality rate of TCA overdose is well known. Class I antiarrhythmic toxicity is associated with a significantly higher mortality rate (22.5%) compared with other drugs (1%).[5] Prompt recognition and treatment are vital to minimize morbidity and mortality.

Enhancing Healthcare Team Outcomes

Management of acute sodium channel blocker toxicity requires an interdisciplinary approach involving ICU, nursing, pharmacy, and multiple other departments.  Nursing is essential to the delivery of the medications to the patient in a timely manner in tandem with the pharmacy.  Treatment will require the involvement of the critical care team, social work, and likely, psychiatry, as there is often a concern for suicidal intent. Ultimately treatment of sodium channel blocker toxicity requires further research, as it is all too often resistant to our best current strategies.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Sodium Channel Blocker Toxicity - Questions

Take a quiz of the questions on this article.

Take Quiz
A 20-year-old presents to the emergency in an active seizure. Friends report that she had taken a large amount of a medication prescribed for stomatitis. On arrival, blood pressure is 80/50 mmHg, pulse 130 bpm, and respiratory rate 8/minute. What medication should be avoided in this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 65-year-old female presents to the emergency department after taking 40 300 mg Imipramine tablets. The patient denied any other ingestion. The patient is distraught but cooperative. Blood pressure is 100/60 mmHg, pulse 140 bpm, respiratory rate 16/minute, and temperature 37.8 C. EKG is obtained and shows sinus tachycardia with a QRS duration of 130 msec. A fluid bolus is initiated. What is the next most appropriate step?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 40-year-old male is having a very large laceration repaired when he suddenly complains of dizziness, headache and suddenly becomes unresponsive. Blood pressure is 60/20 mmHg, heart rate 40 bpm, respiratory rate 8, and pulse oximetry 95% on 4 L of oxygen. EKG shows sinus bradycardia, QRS 80 ms. Two large bore IV’s are inserted, and 2 L fluid boluses are initiated. What is the next medication that should be given?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
On what phase of the action potential do class I antiarrhythmics exert their effects when at toxic levels?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 78-year-old male presents via emergency medical services for ingestion of 200 tabs of 300 mg propafenone. On arrival, the patient moans to painful stimuli but makes no effort to remove the stimuli. Blood pressure is 80/40 mmHg, pulse 130 bpm, respiratory rate 6/minute, and pulse oximetry 89% on nonrebreather mask. What is the most appropriate next intervention?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Sodium Channel Blocker Toxicity - References

References

Mirrakhimov AE,Ayach T,Barbaryan A,Talari G,Chadha R,Gray A, The Role of Sodium Bicarbonate in the Management of Some Toxic Ingestions. International journal of nephrology. 2017     [PubMed]
Grant AO Jr, On the mechanism of action of antiarrhythmic agents. American heart journal. 1992 Apr     [PubMed]
Di Grande A,Giuffrida C,Narbone G,Le Moli C,Nigro F,Di Mauro A,Pirrone G,Tabita V,Alongi B, Management of sodium-channel blocker poisoning: the role of hypertonic sodium salts. European review for medical and pharmacological sciences. 2010 Jan     [PubMed]
Kacirova I,Grundmann M,Kolek M,Vyskocilova-Hrudikova E,Urinovska R,Handlos P, Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone - A first pediatric case report. Forensic science international. 2017 Sep     [PubMed]
Arı ME,Ekici F, Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report. Balkan medical journal. 2017 Sep 29     [PubMed]
Szadkowski M,Drapkin Z,Hewes H,Caravati EM,Plumb J, A Teenager With Seizures and Cardiac Arrest After Drug Overdose: Are We Numb to the Danger? Pediatric emergency care. 2017 Sep     [PubMed]
Rothschild L,Bern S,Oswald S,Weinberg G, Intravenous lipid emulsion in clinical toxicology. Scandinavian journal of trauma, resuscitation and emergency medicine. 2010 Oct 5     [PubMed]
Vu NM,Hill TE,Summers MR,Vranian MN,Faulx MD, Management of life-threatening flecainide overdose: A case report and review of the literature. HeartRhythm case reports. 2016 May     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Podiatry APMLE Part 3. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Podiatry APMLE Part 3, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Podiatry APMLE Part 3, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Podiatry APMLE Part 3. When it is time for the Surgery-Podiatry APMLE Part 3 board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Podiatry APMLE Part 3.